Search For "glenmark"
Glenmark Pharma reports revenue of Rs 27,773 Mn and PAT of Rs 2,111 Mn for
Updated : 1 day, 3 hours ago IST
Mumbai (Maharashtra) [India], August 11 (ANI/PRNewswire): Glenmark Pharmaceuticals Ltd. (Glenmark), an innovation-driven global pharmaceutical company, today announced its financial results for the first quarter ended June 30, 2022.
Read More
Glenmark announces Peer Reviewed Publication of Its Phase 3 Clinical Trial
Updated : 4 weeks, 1 day ago IST
Mumbai (Maharashtra) [India]/ Vancouver [BC], July 13 (ANI/PRNewswire): Glenmark Pharmaceuticals Limited (Glenmark), an innovation-driven, global pharmaceutical company, and SaNOtize Research and Development Corp, today announced that The Lancet Regional Health Southeast Asia (TLRHSEA) - pee
Read More
Glenmark launches sitagliptin and its fixed-dose combinations, at affordab
Updated : 1 month ago IST
Mumbai (Maharashtra) [India], July 8 (ANI/PRNewswire): Glenmark Pharmaceuticals Limited (Glenmark), an innovation-driven global pharmaceutical company has launched sitagliptin and its Fixed Dose Combinations (FDCs), at affordable prices for adults with Type 2 diabetes in India. The company h
Read More
Glenmark Pharmaceuticals Inc., USA continues to expand its Over-The-Counte
Updated : 1 month, 2 weeks ago IST
Mumbai (Maharashtra) [India]/ Mahwah (New Jersey) [US], June 28 (ANI/PRNewswire): Glenmark Pharmaceuticals Ltd., an innovation-driven, global pharmaceutical company, announced that its fully owned subsidiary Glenmark Pharmaceuticals Inc., USA (Glenmark) has acquired the approved Abbreviated
Read More
Glenmark Pharma reports revenue growth of 5.6 per cent YoY Q4; 12.4 per ce
Updated : 2 months, 2 weeks ago IST
Mumbai (Maharashtra) [India], May 30 (ANI/PRNewswire): Glenmark Pharmaceuticals Limited (Glenmark), an innovation-driven global pharmaceutical company, today announced its financial results for the fourth quarter ended March 31, 2022.
Read More
Glenmark Pharma Q4 net profit falls 26 per cent to Rs 173 crore
Updated : 2 months, 2 weeks ago IST
Mumbai (Maharashtra) [India], May 28 (ANI): Glenmark Pharmaceuticals Limited on Saturday reported a net consolidated profit of Rs 172.6 crore for the quarter ended March 2022 as compared to Rs 234 crore recorded in the corresponding period of the last year, registering a decline of 26 per ce
Read More
Glenmark launches 'Hello Skin' - India's first Whatsapp based chatbot to h
Updated : 2 months, 2 weeks ago IST
Mumbai (Maharashtra) [India], May 24 (ANI/PRNewswire): Glenmark Pharmaceuticals Ltd (Glenmark), an innovation-led global pharmaceutical company, has developed a digital patient education tool, 'Hello Skin' in collaboration with the IADVL (Indian Association of Dermatologists, Venereologists
Read More
Glenmark Pharmaceuticals receives sANDA approval for Abiraterone Acetate T
Updated : 2 months, 3 weeks ago IST
Mumbai (Maharashtra) [India], May 20 (ANI/PRNewswire): Glenmark Pharmaceuticals Inc, USA (Glenmark) has received final approval by the United States Food & Drug Administration (US FDA) for Abiraterone Acetate Tablets USP, 500 mg, the generic version of Zytiga®1 Tablets, 500 mg, of J
Read More
Glenmark Pharmaceuticals receives tentative ANDA approval for Calcipotrien
Updated : 3 months ago IST
Mumbai (Maharashtra) [India], May 9 (ANI/PRNewswire): Glenmark Pharmaceuticals Inc., USA (Glenmark) has been granted tentative approval by the United States Food & Drug Administration (U.S. FDA) for Calcipotriene and Betamethasone Dipropionate Foam, 0.005 per cent|0.064 per cent, the gen
Read More
Glenmark receives the 'India Pharma Innovation of the Year' Award from the
Updated : 3 months, 2 weeks ago IST
Mumbai (Maharashtra) [India], April 27 (ANI/PRNewswire): Glenmark Pharmaceuticals Ltd. (Glenmark), an innovation-driven, global pharmaceutical company, today received the 'India Pharma Innovation of the Year' Award and was adjudged runners-up in the 'India Pharma CSR of the Year' category, a
Read More
Glenmark becomes the First Pharmaceutical Company to launch Teneligliptin
Updated : 3 months, 2 weeks ago IST
Mumbai (Maharashtra) [India], April 25 (ANI/PR Newswire): Glenmark Pharmaceuticals Limited (Glenmark), an innovation-driven global pharmaceutical company has launched a novel fixed-dose combination (FDC) of a widely used DPP4 inhibitor (Dipeptidyl Peptidase 4 inhibitor), Teneligliptin, with
Read More
Glenmark Specialty S.A. receives approval for conducting Phase 1 Clinical
Updated : 4 months ago IST
Mumbai (Maharashtra) [India] April 11 (ANI/PRNewswire): Glenmark Pharmaceuticals Limited, an innovation-driven, global pharmaceutical company, announced that its subsidiary Glenmark Specialty S.A. (Glenmark) received approval from the Indian drug regulator, Drug Controller General of India (
Read More